PI3K Signaling in the Ventromedial Hypothalamic Nucleus Is Required for Normal Energy Homeostasis  by Xu, Yong et al.
Cell Metabolism
Short ArticlePI3K Signaling in the Ventromedial Hypothalamic
Nucleus Is Required for Normal Energy Homeostasis
Yong Xu,1,6 Jennifer W. Hill,1,4,6 Makoto Fukuda,1 Laurent Gautron,1 Jong-Woo Sohn,1 Ki-Woo Kim,1 Charlotte E. Lee,1
Michelle J. Choi,1 Danielle A. Lauzon,1 Harveen Dhillon,2 Bradford B. Lowell,2 Jeffrey M. Zigman,1 Jean J. Zhao,3,5,*
and Joel K. Elmquist1,5,*
1Division of Hypothalamic Research, Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical
Center, Dallas, TX 75390, USA
2Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
3Department of Pathology, Harvard Medical School and Department of Cancer Biology Dana-Farber Cancer Institute, Boston,
MA 02115, USA
4Center for Diabetes and Endocrine Research, Department of Physiology and Pharmacology, College of Medicine, The University of Toledo,
Toledo, OH 43614, USA
5These authors contributed equally to this work
6These authors contributed equally to this work
*Correspondence: jean_zhao@dfci.harvard.edu (J.J.Z.), joel.elmquist@utsouthwestern.edu (J.K.E.)
DOI 10.1016/j.cmet.2010.05.002SUMMARY
Phosphatidyl inositol 3-kinase (PI3K) signaling in the
hypothalamus has been implicated in the regulation
of energy homeostasis, but the critical brain sites
where this intracellular signal integrates various
metabolic cues to regulate food intake and energy
expenditure are unknown. Here, we show that mice
with reduced PI3K activity in the ventromedial hypo-
thalamic nucleus (VMH) aremore sensitive to high-fat
diet-induced obesity due to reduced energy expen-
diture. In addition, inhibition of PI3K in the VMH
impaired the ability to alter energy expenditure in
response to acute high-fat diet feeding and food
deprivation. Furthermore, the acute anorexigenic
effects induced by exogenous leptin were blunted
in the mutant mice. Collectively, our results indicate
that PI3K activity in VMH neurons plays a physiologi-
cally relevant role in the regulation of energy
expenditure.
INTRODUCTION
Obesity is now recognized as a global crisis because of its
increasing prevalence and serious comorbidities, including
type 2 diabetes, cancer, and cardiovascular diseases (Reilly
and Rader, 2003). The central nervous system regulates body
weight homeostasis by maintaining a balance between energy
intake and expenditure. Obesity occurs when the homeostatic
networks fail to adapt to excess energy intake, as occurs with
exposure to high-fat diet (HFD). The ventromedial hypothalamic
nucleus (VMH, also known as the VMN) has long been thought
to be an important component of the neural circuits responsible
for the homeostatic regulation of body weight and food intake.
For example, numerous studies showed that lesions of the
VMH produce obesity due to both increased food intake and88 Cell Metabolism 12, 88–95, July 7, 2010 ª2010 Elsevier Inc.decreased energy expenditure (see King, 2006). However,
many of these results were questioned because the electrolytic
insults and knife cuts used to lesion the VMH likely damaged
the surrounding regions (such as the arcuate nucleus) as well
as neuronal fibers passing through the VMH (Gold, 1973). Recent
mouse genetic studies have begun to circumvent these issues
by performing deletion of key genes specifically in VMH neurons.
These studies were based on the finding that a transcription
factor, steroidogenic factor 1 (SF1), is expressed exclusively in
the VMH neurons within the brain (Ikeda et al., 1995). Deletion
of SF1 in mice disrupts VMH structure (Dellovade et al., 2000)
and leads to obesity (Majdic et al., 2002). These findings sup-
ported the model that VMH neurons are physiological regulators
of body weight homeostasis.
Multiple metabolic signals have been demonstrated to regu-
late energy homeostasis via actions in the VMH. For example,
leptin directly activates SF1 neurons in the VMH, and selective
deletion of leptin receptors from SF1 neurons produces obesity
(Bingham et al., 2008; Dhillon et al., 2006). Estrogen acts on the
estrogen receptor a (ERa) expressed by VMH neurons to regu-
late energy expenditure, as animals with ERa knocked down in
the VMH develop obesity due to reduced energy expenditure
(Musatov et al., 2007). Likewise, knockdown of brain-derived
neurotrophic factor (BDNF) in the VMH and dorsomedial hypo-
thalamic nucleus produces hyperphagic obesity (Unger et al.,
2007).
Of interest, all of the aforementioned hormonal and neural
signals have been shown to activate the phosphatidyl inositol
3-kinase (PI3K) signaling pathway in neurons. For example, lep-
tin activates the PI3K pathway in the hypothalamus (Niswender
et al., 2001; Zhao et al., 2002), and pharmacological evidence
indicates that leptin’s effects on feeding (Zhao et al., 2002) and
lipolysis (Buettner et al., 2008) require intact PI3K activity in the
hypothalamus. Similarly, estrogen regulates expression of PI3K
subunits in the hypothalamus, including the VMH, and the
PI3K/Akt cascade mediates estrogen’s actions in hypothalamic
neurons (Malyala et al., 2008). Furthermore, BDNF activates the
PI3K pathway in neurons to promote synaptic formation (Yoshii
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neurons may be a common pathway that integrates metabolic
cues to provide a coordinated control of energy homeostasis.
In the present study, we generated a mouse model with reduced
PI3K signaling specifically in the VMH to assess the physiological
relevance of PI3K in VMH neurons in the regulation of energy
balance.
RESULTS AND DISCUSSIONS
Generation of Mice Lacking PI3K in VMH Neurons
PI3K consists of an 85 kDa regulatory subunit (p85) and a
110 kDa catalytic subunit (p110) (Cantley, 2002). As the primary
insulin-responsive isoform of PI3K, p110a is selectively activated
by the insulin receptor substrate (IRS) signaling complex and is
required for IRS-associated PI3K activity in the hypothalamus
(Foukas et al., 2006; Knight et al., 2006). Thus, we crossed
mice carrying loxP-flanked p110a alleles (p110alox/lox mice)
(Zhao et al., 2006) with transgenic SF1-Cre mice that express
Cre-recombinase driven by SF1 regulatory elements (Dhillon
et al., 2006). These crosses produced mice lacking p110a only
in SF1 neurons (p110alox/lox/SF1-Cre mice) and mice bearing
p110alox/lox alleles alone. The latter group of littermates served
as controls in all experiments.
We first validated the selective deletion of p110a in SF1 cells in
p110alox/lox/SF1-Cre mice. We found that the p110a alleles were
deleted from the genome in tissues that express SF1, including
the hypothalamus, pituitary, adrenal gland, and testis (Zhao
et al., 2001), whereas the p110a allele remained intact in tissues
that do not express SF1 (e.g., the cortex and brainstem) (Fig-
ure S1A available online). Further, we found that p110a mRNA
was significantly reduced in the VMH from p110alox/lox/SF1-Cre
mice, whereas expression of p110b, another p110 isoform pres-
ent in the hypothalamus (Cantley, 2002), was not changed (Fig-
ureS1B). Finally, we crosseda FoxO1GFP reporter allele (Fukuda
et al., 2008) to the mice lacking p110a in SF-1 neurons. This
allowed assessment of PI3K activity specifically in SF1 neurons
bymonitoring FoxO1GFP translocation between the nucleus and
cytoplasm (Fukuda et al., 2008). We found that FoxO1GFP was
localized in both the cytoplasm and nucleus of the SF1 neurons
cultured from FoxO1GFP/SF1-Cre mice (control mice). In
contrast, FoxO1GFP was significantly more concentrated in the
nucleus of the SF1 neurons from the p110alox/lox/FoxO1GFP/
SF1-Cre mice (Figure S1C). Collectively, these results demon-
strate that PI3K and its downstream signaling pathway are dis-
rupted in SF1 neurons in p110alox/lox/SF1-Cre mice.
We then assessed whether deletion of p110a affects the
viability of SF1 neurons in the VMH as assessed by qPCR and
in situ hybridization for SF1 mRNA. We found that SF1 mRNA
was not significantly changed in the VMH of p110alox/lox/SF1-
Cre mice compared to the controls (Figures S1B and S1D).
SF-1 is also expressed in the pituitary, adrenal glands, and
gonads; thus, we assessed levels of glucocorticoids and gonad-
otropins in control and experimental mice. We found no changes
in the serum corticosterone, testosterone, FSH, or LH in
p110alox/lox/SF1-Cre mice (Table S1). Therefore, the metabolic
phenotypes outlined below are not likely due to impaired PI3K
signaling in the pituitary, adrenal glands, or gonads but, rather,
to altered PI3K activity in SF1 VMH neurons.Mice Lacking PI3K in VMHSF1Neurons Develop Obesity
on HFD
Male p110alox/lox/SF1-Cre mice on regular chow showed com-
parable body weight and body composition as their p110alox/lox
littermates (Figures 1A and 1B). However, male mice lacking
p110a in SF1 neurons displayed increased sensitivity to diet-
induced obesity. Specifically, p110alox/lox/SF1-Cre males fed
with HFD showed significantly increased body weight and
adiposity compared to their controls (Figures 1C and 1D).
Elevated circulating leptin levels were observed in these mice
at both fed and fasted conditions (Figure 1E). The obese pheno-
type was not due to the presence of the SF1-Cre transgene per
se, as mice bearing SF1-Cre alone have been shown to have the
same body weight gain as wild-type mice (Dhillon et al., 2006).
Consistent with our observations, VMH lesions have been shown
to increase the susceptibility to diet-induced obesity (Inoue et al.,
1977; Oku et al., 1984). Our results suggest that PI3K signaling in
VMH neurons may play an important role in resisting diet-
induced obesity. However, we did not formally examine whether
the obese phenotypes seen in HFD-fed p110alox/lox/SF1-Cre
mice can be blunted by switching from HFD back to regular
chow, which is characteristically seen in diet-induced obesity
(Enriori et al., 2007; Shi et al., 2009).
Inhibition of PI3K in VMH SF1 Neurons Disrupts
Regulation of Energy Expenditure
The development of obesity in SF1 knockout mice has been
attributed primarily to deficient regulation of energy expenditure
(Majdic et al., 2002). Similar to SF1 knockout mice, we found that
mice lacking p110a in SF1 neurons are not hyperphagic, as body
weight-matched young mice consumed similar amounts of
energy when fed with either chow or HFD (Figures 2A and 2B).
No significant difference in energy expenditure was detected
between chow-fed p110alox/lox/SF1-Cremales and their controls
(data not shown). However, HFD-fed p110alox/lox/SF1-Cre mice
showed significantly reduced energy expenditure (O2 consump-
tion, CO2 production, and heat production) compared to their
body weight-matched p110alox/lox littermates (Figures 2C–2E).
Components of total energy expenditure include energy required
for physical activities, basal metabolism, and thermogenesis
evoked by stimuli such as food intake (Butler and Kozak, 2010;
Castan˜eda et al., 2005). Because neither ambulatory move-
ments nor rearing activities was significantly changed in
p110alox/lox/SF1-Cre mice (Figures 2F and 2G), we conclude that
the decreases in energy expenditure observed in p110alox/lox/
SF1-Cre mice are due to reduced basal metabolic rate and/or
diet-induced thermogenesis.
Diet-induced thermogenesis is the increase in thermogenesis
in response to eating a high-fat diet, which functions to resist
further weight gain. The VMH has been implicated in the regula-
tion of diet-induced thermogenesis, as VMH lesions interrupt the
signal that activates thermogenesis in response to excess
energy intake (Vander Tuig et al., 1985). Thus, we examined
whether PI3K activity in VMH neurons is required for appropriate
thermogenic responses to excess nutrition. When exposed to
HFD feeding, body weight-matched p110alox/lox/SF1-Cre mice
and controls increased O2 consumption, CO2 production, and
heat production. However, the increase in energy expenditure
in p110alox/lox/SF1-Cre mice was significantly less than that inCell Metabolism 12, 88–95, July 7, 2010 ª2010 Elsevier Inc. 89
Figure 1. Deletion of p110a in SF1 Neurons Increases Sensitivity to Diet-Induced Obesity
(A) Weekly body weight was measured in group-housed male mice weaned on regular chow (n = 12/genotype).
(B) Body composition was measured in 15-week-old male mice fed with regular chow (n = 12/genotype).
(C) Weekly body weight was measured in group-housed male mice weaned on HFD (n = 16 or 23/genotype).
(D) Body composition was measured in 18-week-old male mice fed with HFD (n = 10/genotype).
(E) Serum leptin levels were measured in 7-month-old male mice at both fed and fasted conditions (n = 6/genotype).
Data are presented as mean ± SEM. *p < 0.05 and **p < 0.01 between p110alox/lox/SF1-Cre mice and p110alox/lox mice.
Cell Metabolism
PI3K in VMH Controls Energy Balancecontrols (Figures 3A–3C). The impaired thermogenic responses
to HFD feeding in p110alox/lox/SF1-Cre mice were not due to
reductions in food intake, as food intake after being switched
to HFD was comparable between p110alox/lox/SF1-Cre mice
and p110alox/lox mice (Figure 3D). Further, 3 weeks after HFD
feeding, the body weight of p110alox/lox/SF1-Cre mice started
to diverge compared to p110alox/lox mice (Figure 3E), whereas
energy intake of these mice was not significantly different (Fig-
ure 3F). Thus, we conclude that reduced PI3K signaling in
VMH neurons disrupts the adaptation to excess caloric intake,
which may contribute to HFD-induced obesity.
We also assessed the adaptability of p110alox/lox/SF1-Cre
mice to caloric deprivation. Chow-fed mice with matched body
weight were fasted for 24 hr. p110alox/lox/SF1-Cre mice showed
significantly lessweight loss than p110alox/loxmice (Figure 3G). In
addition, we found that the heat production during fasting period
was significantly lower in p110alox/lox/SF1-Cre mice than that in
p110alox/lox mice (Figure 3H). These findings suggest that intact
PI3K signaling in the VMH is also required for the regulation of
energy expenditure in response to food deprivation.
Brown adipose tissue (BAT) plays crucial roles in regulating
energy expenditure (Dulloo, 2002; Lowell and Bachman, 2003).
We therefore examined the expression of the thermogenic genes
in BAT from male mice that had been fed with HFD for 3 weeks.
Uncoupling protein 1 (UCP1) expressed in BAT generates heat
by uncoupling the oxidation of fuel from adenosine triphosphate
production (Niijima et al., 1984; Sell et al., 2004). We found that
UCP1 mRNA levels in p110alox/lox/SF1-Cre BAT were signifi-
cantly reduced compared to controls (Figure 3I), which may, at90 Cell Metabolism 12, 88–95, July 7, 2010 ª2010 Elsevier Inc.least in part, account for the impaired diet-induced thermogene-
sis in the p110alox/lox/SF1-Cre mice. In addition, expression
levels of peroxisome proliferator-activated receptor g (PPARg),
PPARg coactivator 1a (PGC-1a), and PRDM16, factors that
stimulate UCP1 expression (Seale et al., 2007; Sell et al.,
2004), were significantly lower in p110alox/lox/SF1-Cre BAT.
In contrast, the levels of CIDEA and b3 adrenergic receptor in
BAT were not altered (Figure 3I). Taken together, these findings
demonstrate that reduced PI3K activity in VMH neurons leads
to a reduction in the thermogenic functions of BAT by suppress-
ing UCP1 expression. Whereas previous studies indicated
the involvement of VMH in BAT-mediated thermogenesis
(Kageyama et al., 2003; Niijima et al., 1984; Saito et al., 1989;
Sakaguchi et al., 1988), our findings provide a link that couples
altered PI3K signaling in VMH neurons to BAT thermogenesis.
Mice Lacking PI3K in VMH SF1 Neurons Show Blunted
Responses to Acute Leptin
Specific deletion of PIP3 phosphatase (Pten) in leptin receptor-
expressing neurons, which overactivates the PI3K pathway,
causes increased energy expenditure and decreased body
weight (Plum et al., 2007), suggesting that the PI3K pathway
may be downstream of leptin in the regulation of energy homeo-
stasis. However, the critical brain sites where the PI3K pathway
mediates leptin signal to regulate energy homeostasis have not
been fully explored. We found that, in p110alox/lox control mice,
intracerebroventricular (i.c.v.) injections of leptin significantly
inhibited food intake by decreasing both meal size and meal
frequency during a 24 hr period (Figures 4A–4C). In contrast, in
Figure 2. Deletion of p110a in SF1 Neurons Reduces Energy Expenditure
(A and B) Daily food intake was measured in 7-week-old male mice with comparable body weight fed with regular chow (A) or with HFD (B) (n = 11–15/genotype).
(C–G) Seven-week-old chow-fed male mice (n = 11 or 16/genotype) were fed with HFD for 2 weeks andmatched for body weight (p110alox/lox: 23.8 ± 0.7 g versus
p110alox/lox/SF1-Cre: 24.9 ± 0.7 g, p = 0.31), followed by metabolic analyses using the TSE metabolic chambers.
Data are presented as mean ± SEM. *p < 0.05 and **p < 0.01 between p110alox/lox/SF1-Cre mice and p110alox/lox mice.
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intake was significantly blunted (Figure 4A). Leptin-induced
reduction inmeal size trended to be blunted (Figure 4B), whereas
effects of leptin on meal frequency remained unchanged
(Figure 4C). Administration of leptin also promoted fat oxida-
tion in control mice, demonstrated by decreased respiratory
exchange rate (RER), whereas this effect was significantly
blunted in p110alox/lox/SF1-Cre mice (Figure 4D). Body weight
of p110alox/lox mice was significantly reduced 24 hr after leptin
injections, whereas acute leptin administration did not reduce
body weight of p110alox/lox/SF1-Cre mice (Figure 4E). These
results indicate that PI3K signaling in VMH neurons is required
for mediating acute effects of exogenous leptin on energy
homeostasis.
We have identified PI3K-p110a as a mediator downstream of
leptin receptor activation in SF1 neurons. However, it is notable
that we observed differences between mice lacking PI3K in
SF1 neurons compared to mice lacking leptin receptors in
these neurons. For instance, p110alox/lox/SF1-Cre mice do not
show hyperphagia, although the acute appetite-suppressing
responses to exogenous leptin at a pharmacological dose are
blunted in these mice, suggesting that other signaling pathways
may exist, which compensate for impaired PI3K signaling under
resting conditions. Whereas mice lacking leptin receptors in
SF1 neurons develop obesity on both regular chow and HFD
(Bingham et al., 2008; Dhillon et al., 2006), p110alox/lox/SF1-Cremice show increased sensitivity to diet-induced obesity but
maintain normal body weight when fed with regular chow. More-
over, SF1-specific deletion of leptin receptors causes insulin
resistance before onset of obesity (Bingham et al., 2008),
whereas p110alox/lox/SF1-Cre mice do not show deficits in glu-
cose homeostasis (Figure S2). Therefore, it is likely that leptin
actions inSF1neuronsare alsopartlymediatedbyother signaling
pathways, such as the Jak-Stat3 or ERK pathways (Robertson
et al., 2008). Indeed, SF1-specific deletion of suppressor of cyto-
kine signaling-3 (Socs-3), a potent feedback inhibitor of the lep-
tin-induced Jak-Stat3 pathway (Bjørbaek et al., 1998; Howard
et al., 2004), leads to improved glucose homeostasis (Zhang
et al., 2008), supporting the hypothesis that the Jak-Stat3
pathwaymaymediate leptin actions in the SF1 neurons to control
glycemic balance. In summary, our results indicate that PI3K
activity in VMH neurons plays a physiologically relevant role in
the regulation of energy expenditure that may play a key role in
the physiological response to excess intake of calories. More-
over, it will be interesting to assess whether this response is
altered during the development of obesity.EXPERIMENTAL PROCEDURES
Animal Care
Care of all animals and procedures were approved by the UT Southwestern
Medical Center. Mice were housed in a temperature-controlled environmentCell Metabolism 12, 88–95, July 7, 2010 ª2010 Elsevier Inc. 91
Figure 3. Deletion of p110a in SF1 Neurons Disrupts the Thermogenic Regulation in Response to HFD Feeding and Fasting
(A–C) Six-month-old chow-fed male mice (n = 6/genotype) were matched for body weight (p110alox/lox: 37.7 ± 1.4 g versus p110alox/lox/SF1-Cre: 37.4 ± 1.0 g,
p = 0.90) and adapted to the TSE metabolic chambers. The mice were provided with HFD at 17:00 (2 hr prior to dark cycle), and metabolic parameters were
monitored from 24 hr before the HFD feeding until 24 hr after using the TSE metabolic chambers. (Top) Temporal levels of O2 consumption (A), CO2 production
(B), and heat production (C). The arrow indicates the beginning of HFD feeding. (Bottom) Changes in O2 consumption (A), CO2 production (B), and heat production
(C) between the 12 hr dark cycle before HFD feeding and the 12 hr dark cycle after in p110alox/lox/SF1-Cre and p110alox/lox mice.
(D) HFD intake during the 12 hr dark cycle in the TSE chambers.
(E and F) The mice were maintained on HFD for 6 weeks, and weekly body weight gain (E) and energy intake (F) were recorded.
(G–H) Five-month-old chow-fed male mice (n = 6/genotype) were matched for body weight (p110alox/lox: 31.5 ± 0.6 g versus p110alox/lox/SF1-Cre: 32.4 ± 1.1 g,
p = 0.51) and fasted for 24 hr. The body weight loss was measured (G), and heat production was recorded using the TSE chambers (H).
(I) Fourteen-week-old chow-fed mice were fed with HFD for 3 weeks (mean body weight: p110alox/lox: 33.1 ± 3.4 g versus p110alox/lox/SF1-Cre: 38.8 ± 2.6 g,
p = 0.26), and BAT were collected after euthanasia. Messenger RNA levels of indicated BAT genes were quantified with real-time PCR (n = 6 or 7/genotype).
Data are presented as mean ± SEM. *p < 0.05 and **p < 0.01 between p110alox/lox/SF1-Cre mice and p110alox/lox mice.
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mice were fed either standard chow (4% fat, #7001, Harlan-Teklad, Madison,
WI) or HFD (42% fat, #88137, Harlan Teklad), and water was provided ad92 Cell Metabolism 12, 88–95, July 7, 2010 ª2010 Elsevier Inc.libitum. Study animals were male offspring of crosses between p110alox/lox/
SF1-Cre mice and p110alox/lox mice. All of the mice were on a mixed C57BL/
6J;129S6/SvEv background.
Figure 4. Deletion of p110a in SF1 Neurons Blunts the Anorexigenic Effects of Central Leptin
(A–D) Five-month-old chow-fed male mice (n = 4 or 6/genotype) were matched for body weight and received saline (1 ml, i.c.v.) at 16:00 followed by leptin (6 mg in
1 ml saline, i.c.v.) 24 hr later. Leptin-induced reductions in food intake (A), meal size (B), meal frequency (C), and RER (D) were monitored using the TSEmetabolic
chambers.
(E) Leptin-induced weight loss was measured.
Data are presented as mean ± SEM. *p < 0.05 and **p < 0.01 between p110alox/lox/SF1-Cre mice and p110alox/lox mice.
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Bodyweight wasmeasuredweekly from group-housedmice. Daily food intake
wasmeasured in individually housedmice. Body composition was determined
using quantitative magnetic resonance (QMR) (Bruker’s Minispec MQ10,
Houston, TX).Metabolic Chambers
As described before (Xu et al., 2008), meal pattern, physical activity, and
energy expenditure were monitored using a combined indirect calorimetry
system (TSE Systems GmbH, Bad Homburg, Germany) in young chow-fed
or HFD-fed mice. Mice were housed individually at room temperature (22C)
under an alternating 12 hr light/12 hr dark cycle. After adaptation for 6 days,
physical activity was determined for 5 days using a multidimensional infrared
light beam system with beams installed on cage bottom and cage top levels.
Ambulatory movement was defined as breaks of any two different light beams
at cage bottom level, and rearing was recorded when the mouse broke any
light beam at the top levels. Simultaneously, O2 consumption, CO2 production,
and heat production were measured and normalized by metabolic body size
(body weight0.75) to determine the energy expenditure. In addition, meal
patterns were determined continuously by integration of weighing sensors
fixed at the top of the cage from which the food containers have been sus-
pended into the sealed cage environment. Meals were defined as food intake
events with a minimum duration of 60 s and a break of 300 s between food
intake events.
To assess diet-induced thermogenesis, 6-month-old chow-fed mice with
matched body weight were acclimatized in the TSE metabolic chambers as
described above, followed by continuous monitoring of energy expenditure
for 3 days. Chow was provided from day 1 and replaced by HFD at 17:00 of
day 2 (2 hr prior to the start of dark cycle). Body weight was measured at
17:00 on the three successive days.
To assess the thermogenic responses to food deprivation, 5-month-old
micewithmatched bodyweight were acclimatized in the TSEmetabolic cham-
bers, followed by continuous monitoring of energy expenditure for 3 days.
Chow was provided from day 1 and removed at 17:00 of day 2. Body weight
was measured at 17:00 on the three successive days.Responses to I.C.V. Leptin
Stainless steel cannulae were inserted into the lateral ventricles (0.34 mm
caudal and 1 mm lateral from bregma; depth, 2.3 mm) of anesthetized mice
(100 mg/kg ketamine hydrochloride and 6 mg/kg Xylazine i.p.). Mice were
allowed to recover for at least 1 week before i.c.v. injection and were not
used until they regained their presurgery weights. Cannulation placement
was confirmed by demonstration of increased thirst after administration of
angiotensin (10 ng).
Cannulated mice were acclimatized in the TSE metabolic chambers
provided with chow, followed by continuous monitoring of energy expenditure
and food intake for 4 days. Saline (1 ml) was i.c.v. injected at 16:00 of day 2;
leptin (6 mg in 1 ml saline) was i.c.v. injected at 16:00 of day 3. Body weight
was measured at 16:00 of day 2 to day 4. (The dark cycle started at 18:00 at
the time of experiment.)
Statistics
The data are presented as mean ± SEM. Statistical analyses were performed
using SigmaStat 2.03. After confirming normal distribution of data, compari-
sons between two genotypes were made by the unpaired two-tailed Student’s
t test; repeated-measures ANOVA were used to compare changes over time
between two genotypes. p < 0.05 was considered to be statistically significant.
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